IL143927A0 - Nmr spectroscopic in vitro assay using hyperpolarization - Google Patents

Nmr spectroscopic in vitro assay using hyperpolarization

Info

Publication number
IL143927A0
IL143927A0 IL14392799A IL14392799A IL143927A0 IL 143927 A0 IL143927 A0 IL 143927A0 IL 14392799 A IL14392799 A IL 14392799A IL 14392799 A IL14392799 A IL 14392799A IL 143927 A0 IL143927 A0 IL 143927A0
Authority
IL
Israel
Prior art keywords
hyperpolarization
vitro assay
nmr spectroscopic
spectroscopic
nmr
Prior art date
Application number
IL14392799A
Other languages
English (en)
Original Assignee
Nycomed Amersham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9828852.5A external-priority patent/GB9828852D0/en
Priority claimed from GBGB9918096.0A external-priority patent/GB9918096D0/en
Application filed by Nycomed Amersham Plc filed Critical Nycomed Amersham Plc
Publication of IL143927A0 publication Critical patent/IL143927A0/xx

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01RMEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00Arrangements or instruments for measuring magnetic variables
    • G01R33/20Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/28Details of apparatus provided for in groups G01R33/44 - G01R33/64
    • G01R33/281Means for the use of in vitro contrast agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
IL14392799A 1998-12-30 1999-12-23 Nmr spectroscopic in vitro assay using hyperpolarization IL143927A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9828852.5A GB9828852D0 (en) 1998-12-30 1998-12-30 Nmr spectroscopy method
GBGB9918096.0A GB9918096D0 (en) 1999-08-02 1999-08-02 NMR Spectroscopy method
PCT/GB1999/004410 WO2000040988A1 (en) 1998-12-30 1999-12-23 Nmr spectroscopic in vitro assay using hyperpolarization

Publications (1)

Publication Number Publication Date
IL143927A0 true IL143927A0 (en) 2002-04-21

Family

ID=26314943

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14392799A IL143927A0 (en) 1998-12-30 1999-12-23 Nmr spectroscopic in vitro assay using hyperpolarization
IL143927A IL143927A (en) 1998-12-30 2001-06-21 Nmr spectroscopic in vitro assay using hyperpolarization

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL143927A IL143927A (en) 1998-12-30 2001-06-21 Nmr spectroscopic in vitro assay using hyperpolarization

Country Status (7)

Country Link
US (1) US7501236B1 (enExample)
EP (1) EP1141738A1 (enExample)
JP (1) JP2002534687A (enExample)
AU (1) AU766923B2 (enExample)
CA (1) CA2356442C (enExample)
IL (2) IL143927A0 (enExample)
WO (1) WO2000040988A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9911681D0 (en) * 1999-05-19 1999-07-21 Nycomed Imaging As Process
GB0014463D0 (en) 2000-06-14 2000-08-09 Nycomed Amersham Plc NMR Method
GB0022341D0 (en) * 2000-09-12 2000-10-25 Nycomed Imaging As Method
NO20023358D0 (no) * 2002-04-19 2002-07-11 Amersham Health As Metode
NO20023357D0 (no) * 2002-04-19 2002-07-11 Amersham Health As Blanding
GB0219953D0 (en) * 2002-08-29 2002-10-02 Amersham Health R & D Ab An arrangement and a method for providing contrast agents
NO20025738D0 (no) * 2002-11-29 2002-11-29 Amersham Health As Metode
GB0308586D0 (en) 2003-04-14 2003-05-21 Amersham Health R & D Ab Method and arrangements in NMR spectroscopy
NO20035626D0 (no) * 2003-12-17 2003-12-17 Amersham Health As Metode
EP1555538A1 (en) * 2004-01-15 2005-07-20 Bruker BioSpin MRI GmbH Method of fast multidimensional NMR spectroscopy
EP1998813A2 (en) * 2006-03-29 2008-12-10 GE Healthcare AS Method to produce hyperpolarised carboxylates and sulphonates in the presence of inorganic cations
US20100092391A1 (en) * 2007-01-11 2010-04-15 Huntington Medical Research Institutes Imaging agents and methods of use thereof
US20100233089A1 (en) * 2007-10-05 2010-09-16 Huntington Medical Research Institutes Imaging of genetic material with magnetic resonance
EP2902041A1 (en) * 2007-12-19 2015-08-05 GE Healthcare Limited Composition and method for generating a metabolic profile using 13C-MR detection
WO2009129265A1 (en) * 2008-04-14 2009-10-22 Huntington Medical Research Institutes Methods and apparatus for pasadena hyperpolarization
US9678185B2 (en) 2013-03-15 2017-06-13 Pepsico, Inc. Method and apparatus for measuring physico-chemical properties using a nuclear magnetic resonance spectrometer
US10338052B2 (en) 2015-11-30 2019-07-02 Vanderbilt University Methods of detecting sulfur-containing compounds
US20180230182A1 (en) * 2017-02-15 2018-08-16 Cedars-Sinai Medical Center Hyperpolarization of amino acid residues for producing hyperpolarized peptides
DE102018203434B4 (de) * 2018-03-07 2019-12-05 Bernd Willi Karl-Heinz Diehl Verfahren zur heteronuklearen quantitativen Bestimmung mittels NMR-Spektroskopie, Referenzsubstanzen hierfür und Verfahren zur Bestimmung des Deuterierungsgrades einer deuterierten Verbindung
WO2022238350A1 (en) 2021-05-11 2022-11-17 Ecole Polytechnique Federale De Lausanne (Epfl) Dnp biosensor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834226A (en) * 1991-01-31 1998-11-10 Xytronyx, Inc. One-step test for aspartate aminotransferase
US5393669A (en) * 1993-02-05 1995-02-28 Martek Biosciences Corp. Compositions and methods for protein structural determinations
US6103492A (en) * 1993-03-08 2000-08-15 Indiana University Polynucleotide encoding mu opioid receptor
US5475304A (en) 1993-10-01 1995-12-12 The United States Of America As Represented By The Secretary Of The Navy Magnetoresistive linear displacement sensor, angular displacement sensor, and variable resistor using a moving domain wall
US5545396A (en) * 1994-04-08 1996-08-13 The Research Foundation Of State University Of New York Magnetic resonance imaging using hyperpolarized noble gases
US5479925A (en) 1994-06-23 1996-01-02 General Electric Company Magnetic resonance (MR) angiography in a low-field imaging magnet
US5698401A (en) * 1995-11-14 1997-12-16 Abbott Laboratories Use of nuclear magnetic resonance to identify ligands to target biomolecules
EP0904542B1 (en) * 1996-03-01 2005-06-29 Beckman Coulter, Inc. System for simultaneously conducting multiple ligand binding assays
RU2186405C2 (ru) * 1996-03-29 2002-07-27 Лоренс Беркли Нэшнл Лэборэтори Усиление ядерного магнитного резонанса (ямр) и магниторезонансной визуализации (мрв) в присутствии гиперполяризованных благородных газов
US6043024A (en) * 1997-04-18 2000-03-28 Abbott Laboratories Use of one-dimensional nuclear magnetic resonance to identify ligands to target biomolecules
US6278893B1 (en) * 1998-01-05 2001-08-21 Nycomed Imaging As Method of magnetic resonance imaging of a sample with ex vivo polarization of an MR imaging agent
US6574496B1 (en) * 1999-05-19 2003-06-03 Amersham Health As Magnetic resonance imaging

Also Published As

Publication number Publication date
JP2002534687A (ja) 2002-10-15
CA2356442A1 (en) 2000-07-13
EP1141738A1 (en) 2001-10-10
US7501236B1 (en) 2009-03-10
WO2000040988A1 (en) 2000-07-13
AU766923B2 (en) 2003-10-23
CA2356442C (en) 2009-03-24
AU1880300A (en) 2000-07-24
IL143927A (en) 2007-05-15

Similar Documents

Publication Publication Date Title
IL143927A0 (en) Nmr spectroscopic in vitro assay using hyperpolarization
GB2312751B (en) NMR diffusion measurement
AU2001249597A1 (en) Low-field mri
IL118408A0 (en) Spectroscopic probe
GB9907643D0 (en) Measuring probe
GB0009697D0 (en) Improved assay analysis
GB9903309D0 (en) Probe card
GB0108162D0 (en) Biological measurement instrument
IL128167A0 (en) Arterial mri with chemical-shift nulling
GB2351555B (en) Improved assay analysis
EP1311192A4 (en) -G- (IN VIVO) IMAGING
GB9700686D0 (en) Probe for spectroscopic analysis
GB2395267B (en) Improved assay analysis
GB9905569D0 (en) Measuring instrument
GB2326470B (en) Improvements in structural deflection measurement
GB2329038B (en) Spectroscopic analysis
GB2345974B (en) Meter tester
AU2464400A (en) Probe card
AU7773500A (en) Quantitative determination of the xenon content in liquids using nmr spectroscopy
AUPQ224699A0 (en) Homogeneous in vitro diagnostic assays
TW389319U (en) Probe structure
ZA981632B (en) Load measurement
GB9927262D0 (en) Improvements in probes
GB9923227D0 (en) Caravan nose-weight measurement
TW386345U (en) Improved birdcage

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed